The drug metformin has benefits over sulfonylurea drugs, according to a Vanderbilt study examining the impact of the two medications on the risk for heart attack, stroke and death in diabetes. It was important to examine the cardiovascular impact of the more commonly used diabetes drugs after recent controversy surrounded another diabetes medication, rosiglitazone, because it was associated with an increased cardiac risk, said lead author, Christianne L. Roumie, ...
via Medindia Health News
More READ
No comments:
Post a Comment